Updates to Procedures Related to Covid-19
On behalf of the Integrative Safety Committee (ISC), we are writing to provide an update to
COVID19-related procedures as they pertain to research conducted on Tufts campuses,
by Tufts researchers in the field, or by those contracted to perform research on behalf of
Tufts.
1. Beginning April 1, 2022, the wearing of face coverings by researchers, and by
research subjects in the case of human studies research, will follow the
policy of the campus at which the research is being conducted. This change
applies to face coverings worn for COVID-19 related reasons only and does not
impact requirements to wear masks for other safety related purposes. Researchers
are asked to be vigilant regarding Tufts’ policy on face coverings, which may
change as COVID-19 incidence fluctuates in the community. Researchers and
research subjects are strongly encouraged to wear masks during face-to-face
activities whenever possible, even if not required by policy.
Boston: Wearing of face coverings by researchers and research subjects
will be optional on April 1, 2022.
Please note: Certain university spaces (e.g. TUSDM, HNRCA, CABCS)
may have stricter guidance that will need to be followed by researchers and
research subjects. Researchers and research subjects should follow the
face covering policy specific to the location where their research is
conducted.
2. ISC review of domestic research activity, including all research involving
human subjects, is no longer required. At this time, no other mitigations
relevant to COVID-19 transmission are required, beyond adherence to the
appropriate face covering policy in place when the research is conducted. The ISC
will be available as a resource for those investigators who have questions about
how to safely conduct research that may have an elevated risk of COVID-19
transmission. This resource can be accessed by emailing
Tayling.Manoukian@tufts.edu or Phil.Hinds@tufts.edu.
3. Human subjects research in an international setting will continue to undergo
review by the ISC. For guidelines for submitting international human subjects research plans for review, please contact Ann-Marie.Billig@tufts.edu
PLEASE NOTE: The Tufts University Biosafety Office has released guidance to research labs that will be handling and processing human specimens, environmental samples, or other materials known or potentially containing SARS-CoV-2 (COVID-19). This also applies to human specimens in which the SARS-CoV-2 status is unknown. Work with unfixed human specimens requires the use of Universal Precautions and Biosafety Level 2 containment and work practices because all human materials must be treated as potentially infectious.
Moving forward, all human specimens of unknown SARS-COV-2 status, or have tested and were found negative, can be processed for diagnostic testing, histological analysis, nucleic acid extraction, and similar end-point procedures at Biosafety level 2 containment using Universal Precautions. Procedures involving culturing the patient specimens, or SARS-COV-2 positive specimens, need to be performed at Biosafety level 2 with enhancements. Given these guidelines, all research involving the collection or analysis of human source materials will require registration with the Institutional Biosafety Committee (IBC). DRA will assist you with any needed registrations or amendments to current registrations for new studies.
There is also a new training for Tufts personnel that will handling patient samples that may contain COVID-19: Biosafety Overview for Processing COVID-19 Patient Samples – Tufts University.
If your research involved human specimens, please contact Ann-Marie.Billig@tufts.edu to assist you in registering your research the IBC.
Human Specimens Research Resources
- Biosafety Guidelines for SARS-COV-2 (COVID-19) and Research
- IBC Biological Materials Registration form
- SOP for Processing Human Source Material (HSM) From Individuals of COVID-19+ or COVID-19 Unknown Status
- Biosafety Overview for Processing COVID-19 Patient Samples Training
- Basic Biosafety Level 2 (BSL2) Training
- SARS COV-2 (COVID-19) Awareness Training
- Biosafety Overview for Processing COVID-19 Patient Samples – Tufts University